AstraZeneca applies for approval of antibody treatment that provides passive immunity against COVID-19 for up to a year according to the press release. Indicated for vulnerable people who are immunocompromised or who have not responded to the vaccine.

Medical Mythbusting Commentary for November 4, 2021


Health Canada to review AstraZeneca’s antibody therapy that could prevent COVID-19